Evidence map›Paper›PMID 34151144›Full record

ArticleAccess microbiology2021

Hybrid genome assembly of

Dhiviya Prabaa Muthuirulandi Sethuvel, Shalini Anandan, Dhivya Murugan, Kalaiarasi Asokan, Karthick Vasudevan, Jobin John Jacob, Kamini Walia, Joy Sarojini Michael, Balaji Veeraraghavan

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Access microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 61% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Dhiviya Prabaa Muthuirulandi SethuvelDepartment of Clinical Microbiology, Christian Medical College, Vellore 632004, India.
Shalini AnandanDepartment of Clinical Microbiology, Christian Medical College, Vellore 632004, India.
Dhivya MuruganDepartment of Clinical Microbiology, Christian Medical College, Vellore 632004, India.
Kalaiarasi AsokanDepartment of Clinical Microbiology, Christian Medical College, Vellore 632004, India.
Karthick VasudevanDepartment of Clinical Microbiology, Christian Medical College, Vellore 632004, India.
Jobin John JacobDepartment of Clinical Microbiology, Christian Medical College, Vellore 632004, India.
Kamini WaliaDivision of Epidemiology and Communicable Diseases, Indian Council of Medical Research, New Delhi 110029, India.
Joy Sarojini MichaelDepartment of Clinical Microbiology, Christian Medical College, Vellore 632004, India.
Balaji VeeraraghavanDepartment of Clinical Microbiology, Christian Medical College, Vellore 632004, India.ORCID https://orcid.org/0000-0002-8662-4257
Christian Medical College, Vellore · INIndian Council of Medical Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Azithromycin is increasingly being used for the treatment of shigellosis despite a lack of interpretative guidelines and with limited clinical evidence. The present study determined azithromycin susceptibility and correlated this with macrolide-resistance genes in

Indexed as

azithromycinermBhybrid assemblyIncFII plasmidmphAS. sonnei

Identifiers

PMID34151144
PMCPMC8209639
OpenAlexW3110801040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.